Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
She is a graduate of Rider University, where she acquired a Bachelors of Art in journalism, as well as a graduate of Temple University, where she received her Masters of Science in Sports Management.
Follow Kristie on Twitter at @KristieLKahl, or email her at kkahl@mjhlifesciences.com.
Blue Faery Helps Patients Spread Their Wings After Liver Cancer Diagnosis
December 21st 2017Blue Faery, the Adrienne Wilson Liver Cancer Association, is a nonprofit corporation founded in 2002, with the intent to prevent, treat and cure primary liver cancer – particularly HCC – through research, education and advocacy. Its name, inspired by Adrienne, has a unique background.
Read More
Elderly Patients Significantly Underrepresented in Hematology Clinical Trials
December 12th 2017Patients aged 75 years or older diagnosed with hematologic malignancies appear significantly underrepresented in clinical trials submitted to the U.S. Food and Drug Administration (FDA), according to a retrospective analysis.
Read More
Alternative Chemotherapy Dosing Strategies Improve Breast Cancer Outcomes
December 6th 2017For women with early-stage breast cancer who are receiving chemotherapy, shortening the time between treatment cycles or administering the agents sequentially may reduce disease recurrence and mortality compared with standard chemotherapy regimens.
Read More
Penn Medicine Launches Smoking Cessation Program
November 20th 2017Physicians at Penn Medicine’s Abramson Cancer Center in Philadelphia are ready to launch their new treatment program designed to help patients with cancer to quit smoking. The program is intended to provide patients with “state-of-the-science” tobacco use treatment, while also assisting patients with their medical treatment and recovery.
Read More
Cooking with Olive Oil: Lose Weight, Decrease Risk for Prostate Cancer Progression
November 17th 2017Data from a pilot study showed an added benefit from the incorporation of extra virgin olive oil into the diets of men with low-risk prostate cancer. As a result, this dietary modification could lead to weight loss, while also helping the body to absorb compounds with anticancer properties.
Read More